Abstract: A system for alleviating variations in torsional loads applied to a shaft coupled to a main engine of a marine vessel, said shaft is coupled to a propeller of the marine vessel, the system comprising an electric motor-generator configured to provide power to the shaft or take out power from the shaft; a controller coupled to the electric motor-generator said controller is configured to execute instructions, comprising: measuring a group of values that are indicative of torsional loads applied on a shaft of the marine vessel over time; creating a time-based series of values that represent a predictive time-based torsional loads on the marine vessel; collecting readings indicative of power provided by a main engine of the marine vessel; computing an intervention time series of power values to be outputted by the electric motor-generator; wherein the electrical power outputs the intervention time series values of power to the shaft.

Abstract: A system for alleviating variations in torsional loads applied to a shaft coupled to a main engine of a marine vessel, said shaft is coupled to a propeller of the marine vessel, the system comprising an electric motor-generator configured to provide power to the shaft or take out power from the shaft; a controller coupled to the electric motor-generator said controller is configured to execute instructions, comprising: measuring a group of values that are indicative of torsional loads applied on a shaft of the marine vessel over time; creating a time-based series of values that represent a predictive time-based torsional loads on the marine vessel; collecting readings indicative of power provided by a main engine of the marine vessel; computing an intervention time series of power values to be outputted by the electric motor-generator; wherein the electrical power outputs the intervention time series values of power to the shaft.

Abstract: A ball game apparatus including a centerpiece apparatus member having an outer frame member, an inner frame member, and a raised platform surface disposed within the inner frame member, a plurality of shaped members coupled between the outer and inner frame members, and a ball member configured to bounce off the raised platform surface and the plurality of shaped members.

Abstract: A system for alleviating variations in torsional loads applied to a shaft coupled to a main engine of a marine vessel, said shaft is coupled to a propeller of the marine vessel, the system comprising an electric motor-generator configured to provide power to the shaft or take out power from the shaft; a controller coupled to the electric motor-generator said controller is configured to execute instructions, comprising: measuring a group of values that are indicative of torsional loads applied on a shaft of the marine vessel over time; creating a time-based series of values that represent a predictive time-based torsional loads on the marine vessel; collecting readings indicative of power provided by a main engine of the marine vessel; computing an intervention time series of power values to be outputted by the electric motor-generator; wherein the electrical power outputs the intervention time series values of power to the shaft.

Abstract: A ball game apparatus including a centerpiece apparatus member having an outer frame member, an inner frame member, and a raised platform surface disposed within the inner frame member, a plurality of shaped members coupled between the outer and inner frame members, and a ball member configured to bounce off the raised platform surface and the plurality of shaped members.

Abstract: Provided are methods of treating patients suffering from or susceptible to at least one symptom of abuse of, dependence on, or withdrawal from at least one substance with Compound A. Also provided are methods of treating at least one phase of substance dependence on at least one substance in patients and certain methods of treating at least one phase of cocaine dependence in patients.

Abstract: Corticosteroid microparticle formulations are provided for use for treating pain, including pain caused by inflammatory diseases such as osteoarthritis or rheumatoid arthritis, and for slowing, arresting or reversing structural damage to tissues caused by an inflammatory disease, for example damage to articular and/or peri-articular tissues caused by osteoarthritis or rheumatoid arthritis. Corticosteroid microparticle formulations are administered locally as a sustained release dosage form (with or without an immediate release component) that results in efficacy accompanied by clinically insignificant or no measurable effect on endogenous cortisol production.

Abstract: A method operable in a towing vehicle for determining a state of a trailer being towed by said towing vehicle is disclosed. The vehicle comprises a front facing and a rear facing image capturing device and the method comprises determining respective distances of the rear facing image capturing device and the front facing image capturing device from a surface on which the vehicle lies. Responsive to one or both of: the distance of the rear image capturing device being outside a first threshold, and the distance of the front image capturing device being outside a second threshold, a value indicative the state of the towed trailer is output.

Abstract: Provided are methods of treating patients suffering from or susceptible to at least one symptom of abuse of, dependence on, or withdrawal from at least one substance with Compound A. Also provided are methods of treating at least one phase of substance dependence on at least one substance in patients and certain methods of treating at least one phase of cocaine dependence in patients.

Abstract: Corticosteroid microparticle formulations are provided for use for treating pain, including pain caused by inflammatory diseases such as osteoarthritis or rheumatoid arthritis, and for slowing, arresting or reversing structural damage to tissues caused by an inflammatory disease, for example damage to articular and/or peri-articular tissues caused by osteoarthritis or rheumatoid arthritis. Corticosteroid microparticle formulations are administered locally as a sustained release dosage form (with or without an immediate release component) that results in efficacy accompanied by clinically insignificant or no measurable effect on endogenous cortisol production.

Abstract: Corticosteroid microparticle formulations are provided for use for treating pain, including pain caused by inflammatory diseases such as osteoarthritis or rheumatoid arthritis, and for slowing, arresting or reversing structural damage to tissues caused by an inflammatory disease, for example damage to articular and/or peri-articular tissues caused by osteoarthritis or rheumatoid arthritis. Corticosteroid microparticle formulations are administered locally as a sustained release dosage form (with or without an immediate release component) that results in efficacy accompanied by clinically insignificant or no measurable effect on endogenous cortisol production.

Abstract: A method to determine the volume of a box object from the captured image of the box object. The method includes identifying a geometric mark on the box object in the captured image to find the positions of two reference points of the geometric mark. The two reference points are separated by a predetermined distance. The method also includes processing a group of parameters and a predetermined mapping obtained from a calibration process. The group of parameters includes the positions of the two reference points and the predetermined distance separating the two reference points.

Abstract: Corticosteroid microparticle formulations are provided for use for treating pain, including pain caused by inflammatory diseases such as osteoarthritis or rheumatoid arthritis, and for slowing, arresting or reversing structural damage to tissues caused by an inflammatory disease, for example damage to articular and/or peri-articular tissues caused by osteoarthritis or rheumatoid arthritis. Corticosteroid microparticle formulations are administered locally as a sustained release dosage form (with or without an immediate release component) that results in efficacy accompanied by clinically insignificant or no measurable effect on endogenous cortisol production.

Abstract: Corticosteroid microparticle formulations are provided for use for treating pain, including pain caused by inflammatory diseases such as osteoarthritis or rheumatoid arthritis, and for slowing, arresting or reversing structural damage to tissues caused by an inflammatory disease, for example damage to articular and/or peri-articular tissues caused by osteoarthritis or rheumatoid arthritis. Corticosteroid microparticle formulations are administered locally as a sustained release dosage form (with or without an immediate release component) that results in efficacy accompanied by clinically insignificant or no measurable effect on endogenous cortisol production.

Abstract: Corticosteroid microparticle formulations are provided for use for treating pain, including pain caused by inflammatory diseases such as osteoarthritis or rheumatoid arthritis, and for slowing, arresting or reversing structural damage to tissues caused by an inflammatory disease, for example damage to articular and/or peri-articular tissues caused by osteoarthritis or rheumatoid arthritis. Corticosteroid microparticle formulations are administered locally as a sustained release dosage form (with or without an immediate release component) that results in efficacy accompanied by clinically insignificant or no measurable effect on endogenous cortisol production.

Abstract: Corticosteroid microparticle formulations are provided for use for treating pain, including pain caused by inflammatory diseases such as osteoarthritis or rheumatoid arthritis, and for slowing, arresting or reversing structural damage to tissues caused by an inflammatory disease, for example damage to articular and/or peri-articular tissues caused by osteoarthritis or rheumatoid arthritis. Corticosteroid microparticle formulations are administered locally as a sustained release dosage form (with or without an immediate release component) that results in efficacy accompanied by clinically insignificant or no measurable effect on endogenous cortisol production.

Abstract: A method to determine the volume of a box object from the captured image of the box object. The method includes identifying a geometric mark on the box object in the captured image to find the positions of two reference points of the geometric mark. The two reference points are separated by a predetermined distance. The method also includes processing a group of parameters and a predetermined mapping obtained from a calibration process. The group of parameters includes the positions of the two reference points and the predetermined distance separating the two reference points.

Abstract: Corticosteroid microparticle formulations are provided for use for treating pain, including pain caused by inflammatory diseases such as osteoarthritis or rheumatoid arthritis, and for slowing, arresting or reversing structural damage to tissues caused by an inflammatory disease, for example damage to articular and/or peri-articular tissues caused by osteoarthritis or rheumatoid arthritis. Corticosteroid microparticle formulations are administered locally as a sustained release dosage form (with or without an immediate release component) that results in efficacy accompanied by clinically insignificant or no measurable effect on endogenous cortisol production.

Abstract: Corticosteroid microparticle formulations are provided for use for treating pain, including pain caused by inflammatory diseases such as osteoarthritis or rheumatoid arthritis, and for slowing, arresting or reversing structural damage to tissues caused by an inflammatory disease, for example damage to articular and/or peri-articular tissues caused by osteoarthritis or rheumatoid arthritis. Corticosteroid microparticle formulations are administered locally as a sustained release dosage form (with or without an immediate release component) that results in efficacy accompanied by clinically insignificant or no measurable effect on endogenous cortisol production.

Abstract: Corticosteroid microparticle formulations are provided for use for treating pain, including pain caused by inflammatory diseases such as osteoarthritis or rheumatoid arthritis, and for slowing, arresting or reversing structural damage to tissues caused by an inflammatory disease, for example damage to articular and/or peri-articular tissues caused by osteoarthritis or rheumatoid arthritis. Corticosteroid microparticle formulations are administered locally as a sustained release dosage form (with or without an immediate release component) that results in efficacy accompanied by clinically insignificant or no measurable effect on endogenous cortisol production.